Research Note 1 of 2021
Prevalence of chronic conditions among medical scheme beneficiaries that are eligible for Phase II of the COVID-19 vaccination. The Minister of Health, Dr Zweli Mkize, announced that Phase II of COVID-19 vaccinations would be commencing on 17 May 2021. This phase includes the vaccination of people
Press Release 5 of 2021: The selection of Designated Service Providers and excessive co-payments
The CMS has received a high volume of queries following the recent publication of the Government Gazette Notice 214 of 2021, read with Circular 31 of 2021, regarding the future of Designated Service Providers (DSPs) and co-payments. The CMS hereby wishes to clarify that DSPs and
PMB definition guidelines: Haematology oncology
The CMS has published PBM definition guidelines on heamatology oncology conditions. These are are open for stakeholder comments until 30 June 2021. Hodgkin’s lymphoma Cutaneous T-cell lymphoma Multiple Myeloma Acute myeloid leukemia Myelodysplastic syndromes The documents are open for stakeholder comments until the 30th of June
Press Release 4 of 2021: KeyHealth Medical Scheme curatorship confirmed
The journey of restoring governance at KeyHealth Medical Scheme continues. This follows the curatorship confirmation by the High Court of South Africa on 25 March 2021, in a judgment by Honourable Judge Kollapen. The Scheme had been placed under provisional curatorship on 16 September 2020, through
Press Release 3 of 2021: CMS releases the COVID-19 Vaccines Survey results
“The majority of medical scheme members want to get vaccinated, with the Johnson and Johnson vaccine as their preferred choice,” according to a study released by the Council for Medical Schemes (CMS), today. The CMS conducted an online survey to gauge support for COVID-19 vaccination by
Press Release 2 of 2021: CMS collaborates with HPCSA to host FWA webinars
Following the inquiry into allegations of unfair racial discrimination and procedural unfairness by medical schemes, the Council for Medical Schemes (CMS) in collaboration with the Health Professions Council of South Africa (HPCSA) will be hosting the Fraud Waste and Abuse (FWA) webinar on Thursday, 11
FWA Webinar 2021
The Council for Medical Schemes (CMS) is proud to announce that the 2021 FWA Summit will take place in the form of an online webinar. The 2021 Fraud, Waste and Abuse Webinar aims at setting the scene for the establishment of Codes of Good Practice and Standards for
Graduate Internship Programme
The CMS is offering a Graduate Internship Programme for unemployed graduates between the ages of 18 and 35, who are in possession of an appropriate qualification in order to gain work-related experience. The following internship positions are available: Supply Chain Management Intern Human Resources Intern Risk
CMScript: Focus on Substance Use Disorders
How do medical schemes treat substance abuse and what is covered under PMB regulations? The PMB regulations include substance abuse and the use of drugs under the following Diagnostic Treatment Pairs (DTP): DTP Code DTP Description Treatment 182T Abuse or dependence on Psychoactive substance, including alcohol Hospital-based management up to 3 weeks/year 910T Acute
CMScript: Focus on Glaucoma
Glaucoma is a PMB condition, which means that all medical schemes are required by law to pay for the diagnosis, treatment, and care of glaucoma regardless of the member’s benefit option. Treatment and care of Glaucoma is explained in terms of the PMB Regulations. Glaucoma is